WELCOME TO THE PENN INTERVENTIONAL PSYCHIATRY NETWORK

The Interventional Psychiatry Program at The University of Pennsylvania offers invasive and non-invasive, inpatient and outpatient-based forms of brain stimulation therapy. 

Clinically it offers treatments with proven effectiveness and with U.S. Food and Drug Administration (FDA) approval for mood disorders and obsessive-compulsive disorders (OCD). 

The Interventional Psychiatry Program at The University of Pennsylvania also participates in clinical research including multisite clinical trials of emerging treatment modalities that involve neuromodulation and intra- and inter-department collaborations to advance knowledge and expand clinical use of neuromodulation techniques.

Offered treatments include:                                          

Our program is one of the leading treatment centers in the U.S. with more than a decade of clinical experience with office-based neuromodulation techniques and with psychiatric neurosurgical treatment modalities. Based in the outpatient treatment facility of the Department of Psychiatry of The University of Pennsylvania at 3535 Market Street, our center is directed by experts on mood and anxiety disorders, invasive and non-invasive neuromodulation, and Esketamine to ensure adequacy of treatment and to maximize chances of treatment response.

PENN’s Interventional Psychiatry Network has multiple academic, research, and clinical affiliations including: